Nationality
US
Year of Birth
1977
1999
Microbiology at Miami University in Oxford, Ohio, B.A.
2006
Business Administration at University of California, San Diego, MBA
2002–2008
Roche Diagnostics, Various Account / Product Manager Roles
2008–2010
Japan / APAC, Tokyo, Commercial Operations Manager
2010–2012
Taiwan, Taipei City, Director Applied Science / Director Molecular Diagnostics
2012–2014
Roche Diagnostics Ireland, Dublin, Country Manager
2014–2016
Roche Pharmaceuticals Peru, Lima, President / General Manager
2016–2018
Roche Pharmaceuticals Korea, Seoul, President / General Manager
2018–2019
Genentech, USA, Vice President, Lifecycle Leader Tecentriq Lung and Head and Neck Cancers
2019
Gilead Sciences, Foster City, USA, Senior Vice-President, Head of Global Commercial Product Strategy
2019–2022
Roche Diagnostics Corporation North America, Indianapolis, USA, President & CEO
Since 2023
Roche Diagnostics Basel, CEO, Member of the Corporate Executive Committee
–
–
Since 2019
AdvaMed, Board Member
–
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.